Halofantrine in the treatment of uncomplicated falciparum malaria with a three-dose regimen in Papua New Guinea: A preliminary report

Papua and New Guinea Medical Journal

Volumn , Issue 1, 1998, Pages 23-29

  Hombhanje, F W ^a   Kereu, R K ^b   Bulungol, P ^b   Paika, R ^b  

^a UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^b Tabubil Medical Centre   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DRUG; HALOFANTRINE; PHENANTHRENE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BIOLOGY; BLOOD; CLINICAL RESEARCH; CLINICAL TRIAL; DEVELOPING COUNTRY; DISEASES; ELECTROCARDIOGRAPHY; EVALUATION; GASTROINTESTINAL EFFECTS; HEALTH; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MELANESIA; METHODOLOGY; MIDDLE AGED; PACIFIC ISLANDS; PAPUA NEW GUINEA; PARASITE CONTROL; PARASITOSIS; PHYSIOLOGY; PUBLIC HEALTH; RESEARCH REPORT; RISK ASSESSMENT; TREATMENT;

BIOLOGY; CLINICAL RESEARCH; DEVELOPING COUNTRIES; DISEASES; DRUGS; EVALUATION; GASTROINTESTINAL EFFECTS; HEALTH; MALARIA; MELANESIA; OCEANIA; PAPUA NEW GUINEA; PARASITE CONTROL; PARASITIC DISEASES; PHYSIOLOGY; PUBLIC HEALTH; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK ASSESSMENT; TREATMENT;

ADOLESCENT; ADULT; ANTIMALARIALS; ELECTROCARDIOGRAPHY; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PHENANTHRENES;

EID: 0032008645     PISSN: 00311480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dulay IS, Gibson FD, Eyeson-Annan MB, Narara A. Chloroquine resistance in Plasmodium falciparum and its geographical distribution in Papua New Guinea. PNG Med J 1987;30:281-290.
2. Trenholme KR, Kum DE, Raiko AK, Gibson N, Narara A, Alpers MP. Resistance of Plasmodium falciparum to amodiaquine in Papua New Guinea. Trans R Soc Trop Med Hyg 1993;87:464-466.
3. Al-Yaman F, Genton B, Mokela D, Alpers MP. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar. PNG Med J 1994;37:54-56.
4. Rinehart J, Arnold J, Canfield CJ. Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. Am J Trop Med Hyg 1976;25:769-774.
5. Monlun E, Le Metayer P, Szwandt S, Neau D, Longy-Boursier M, Horton J. Cardiac complications of halofantrine: a prospective study of 20 patients. Trans R Soc Trop Med Hyg 1995;89:430-433.
6. Boudreau EF, Pang LW, Dixon KE, Webster HK, Pavanand K, Tosingha L, Somutsakorn P, Canfield CJ. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Bull World Health Organ 1988;66:227-235.
7. Wirima J, Khoromana C, Molyneux ME, Gilles HM. Clinical trials with halofantrine hydrochloride in Malawi. Lancet 1988;2:250-252.
8. Watkins WM, Oloo JA, Lury JD, Mosoba M, Kariuki D, Mjomba M, Koech DK, Gilles HM. Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya. Lancet 1988;2:247-250.
9. Salako LA, Sowunmi A, Walker O. Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Trans R Soc Trop Med Hyg 1990;84:644-647.
10. Salazar NP, Carlos CC, Bustos DG, Quiambao BP, Saniel MC, Santos MN. Halofantrine in the treatment of acute uncomplicated falciparum malaria in the Philippines. Southeast Asian J Trop Med Public Health 1991;22:386-392.
11. Richard-Lenoble D, Kombila M, Martz M, Gendrel D, Gendrel C, Moreno JL, Engohan E, Blanc G, Dupasquier I, Iannascoli F. Efficacy, safety and acceptability of halofantrine in the treatment of acute Plasmodium falciparum malaria in African children (Gabon). J Trap Pediatr 1992;38:7-11.
12. Weinke T, Loscher T, Fleischer K, Kretschmer H, Pohle HD, Kohler B, Schlunk T, Clemens R, Bock HL. The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelers. Am J Trap Med Hyg 1992;47:1-5.
13. Sowunmi A, Walker O, Salako LA. Pruritus and antimalarial drugs in Africans. Lancet 1989;2:213.
14. Hallwood PM, Horton RJ, O'Sullivan KM, Parr SN. Halofantrine and pruritus. Lancet 1989;2:397-398.
15. Gillespie SH, Msaki EP, Ramsay A, Ngowi FI, Fox R. A new micronized formulation of halofantrine hydrochloride in the treatment of acute Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993;87:467-469.
16. Ezeamuzie IC, Igbigbi PS, Ambakederemo AW, Abila B, Nwaejike IN. Halofantrine-induced pruritus amongst subjects who itch to chloroquine. J Trop Med Hyg 1991;94:184-188.
17. Vachon F, Fajac I, Gachot B, Coulaud JP, Charmot G. Halofantrine and acute intravascular haemolysis. Lancet 1992;340:909-910.
18. Baudon D, Bernard J, Moulia-Pelat JP, Martet G, Sarrouy J, Touze JE, Spiegel A, Lantrade P, Picq JJ. Halofantrine to prevent falciparum malaria on return from malarious areas. Lancet 1990;336:377.
19. Karbwang J, Na Bangchang K, Bunnag D, Harinasuta T, Laothavorn P. Cardiac effects of halofantrine. Lancet 1993;342:501.
20. Nosten F, ter Kuile FO, Luxemberger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341:1054-1056.
21. Monlun E, Pillet O, Cochard JF, Favarel Garrigues JCL, le Bras M. Prolonged QT interval with halofantrine. Lancet 1993;341:1541-1542.
22. Restrepo M, Botero D, Marquez RE, Boudreau EF, Navaratnam V. A clinical trial with halofantrine on patients with falciparum malaria in Colombia. Bull World Health Organ 1996;74:591-597.
23. Touze JE, Bernard J, Keundjian A, Imbert P, Viguier A, Chaudet H, Doury JC. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg 1996;54:225-228.
24. Matson PA, Luby SP, Redd SC, Rolka HR, Meriwether RA. Cardiac effects of standard-dose halofantrine therapy. Am J Trop Med Hyg 1996;54:229-231.
25. Veenendaal JR, Parkinson AD, Kere N, Rieckmann KH, Edstein MD. Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple-dose regimen of halofantrine. Eur J Clin Pharmacol 1991;41:161-164.
26. Shanks GD, Edstein MD, Kereu RK, Spicer PE, Rieckmann KH. Postexposure administration of halofantrine for the prevention of malaria. Clin Infect Dis 1993;17:628-631.
27. World Health Organization. Bench aids for the diagnosis of malaria: method of counting malaria parasites in thick blood films. Set No 2, Plate 8. Geneva: WHO, 1985.
28. Abdalla SH. Peripheral blood and bone marrow leucocytes in Gambian children with malaria: numerical changes and evaluation of phagocytosis. Ann Trop Paediatr 1988;8:250-258.
29. Davis TM, Ho M, Supanaranond W, Looareesuwan S, Pukrittayakamee S, White NJ. Changes in the peripheral blood eosinophil count in falciparum malaria. Acta Trop 1991;48:243-246.
30. Hall AP. The treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 1977;71:367-378.
31. Watt G, Shanks GD, Phintuyolhin P. Prognostic significance of rises in parasitaemia during treatment of falciparum malaria. Trans R Soc Trop Med Hyg 1992;86:359-360.
32. Munger RG, Prineas RJ, Crow RS, Changbumrung S, Keane V, Wangsuphachart V, Jones MP. Prolonged QT interval and risk of sudden death in South-East Asian men. Lancet 1991;338:280-281.
33. Karbwang J, Milton KA, Na Bangchang K, Ward SA, Edwards G, Bunnag D. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. Br J Clin Pharmacol 1991;31:484-487.